ArticleOncotarget2017

TP53-based interaction analysis identifies cis-eQTL variants for TP53BP2, FBXO28, and FAM53A that associate with survival and treatment outcome in breast cancer.

Rainer Fagerholm et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.